Nontuberculous mycobacteria in solid organ transplant recipients

American Journal of Transplantation

Volumn 9, Issue SUPPL. 4, 2009, Pages

  Dorman, S ^a   Subramanian, A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Infection; Nontuberculous mycobacteria; Transplant

Indexed keywords

AMIKACIN; AZITHROMYCIN; CALCINEURIN INHIBITOR; CAPREOMYCIN; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; COTRIMOXAZOLE; CYCLOSERINE; CYCLOSPORIN; DOXYCYCLINE; ETHAMBUTOL; ETHIONAMIDE; IMIPENEM; ISONIAZID; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MINOCYCLINE; MOXIFLOXACIN; PYRIDOXINE; RIFABUTIN; RIFAMPICIN; RIFAMYCIN; STREPTOMYCIN; SULFAMETHOXAZOLE; SULFONAMIDE; TIGECYCLINE; TOBRAMYCIN;

ATYPICAL MYCOBACTERIOSIS; CHRONIC LUNG DISEASE; GRAFT RECIPIENT; HUMAN; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; NONHUMAN; NONTUBERCULOUS MYCOBACTERIA; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; HUMANS; MYCOBACTERIUM; ORGAN TRANSPLANTATION;

EID: 72949112052     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02895.x     Document Type: Review

References (34)

1. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: The new mycobacteria of the 1990s. Clin Microbiol Rev 2003 16 : 319 354.
2. Brown BA, Wallace RJ Jr. Infections due to nontuberculous mycobacteria. In : Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennet's principles and practice of infectious diseases. 6th Ed. Philadelphia, PA : Churchill-Livingstone, 2005.
3. Griffith DE, Aksamit T, Brown-Elliot B et al. An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007 175 : 367 416.
4. Doucette K, Fishman JA. Nontuberculous mycobacterial infection in hematopoetic stem cell and solid organ transplant recipients. Clin Infect Dis 2004 38 : 1428 1439.
5. Patel R, Roberts GD, Keating MR et al. Infections due to nontuberculous mycobacteria in kidney, heart and liver transplant recipients. Clin Infect Dis 1994 19 : 263 273.
6. Wolinsky E. State of the art: Nontuberculous mycobacteria and associated diseases. Am Rev Resp Dis 1979 1979 : 107 159.
7. Falkinham JO. Nontuberculous mycobacteria in the environment. Clin Chest Med 2002 23 : 520 551.
8. Lloveras J, Peterson PK, Simmons RL, Najarian JS. Mycobacterial infections in renal transplant recipients. Arch Intern Med 1982 142 : 888 892.
9. Novick RJ, Moreno-Cabral, CE, Stinson EB et al. Nontuberculous mycobacterial infections in heart transplant recipients: A seventeen-year experience. J Heart Transplant 1990 9 : 357 363.
10. McDiarmid SV, Blumberg DA, Remotti H et al. Mycobacterial infections after pediatric liver transplantation: A report of three cases and review of the literature. J Pediatr Gastroenterol Nutr 1995 20 : 425 431.
11. Roy V, Weisdorf D. Typical and atypical mycobacterium. In : Bowden R, Ljungman P, Paya CV, eds. Transplant Infections, Philadelphia : Lippincott Raven, 1998.
12. Malouf MA, Lanville AR. The spectrum of mycobacterial disease after lung transplantation. Am J Resp Crit Care Med 1999 160 : 1611 1616.
13. Wallace RJ Jr., Brown BA. Mycobacterium fortuitum, chelonae, abscessus. In Schlossberg D, ed. Tuberculosis and Nontuberculous Mycobacterial Infections, 4th Ed. Philadelphia : Saunders, 1999 : 372 379.
14. Gombert ME, Goldstein EJ, Corrado ML et al. Disseminated Mycobacterium marinum infection after renal transplantation. Ann Intern Med 1981 81 : 486 487.
15. Saubolle MA, Kiehn TE, White MH et al. Mycobacterium haemophilum: Microbiology and expanding clinical and geographic spectra of disease in humans. Clin Micro Rev 1996 9 : 435 447.
16. Nightingale SD, Cameron DW, Gordin FM et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993 329 : 828 833.
17. Pierce M, Crampton S, Henry D et al. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients advance acquired immunodeficiency syndrome. N Engl J Med 1996 335 : 384 391.
18. Havlir DV, Dubé MP, Sattler FR et al. Prophylaxis against Mycobacterium avium complex with weekly azithromycin, daily rifabutin or both. N Engl J Med 1996 335 : 392 398.
19. Kesten S, Chapparo C. Mycobacterial infections in lung transplant recipients. Chest 1999 115 : 741 745.
20. NCCLS: Susceptibility testing of Mycobacteria, Nocardia and other Aerobic Actinomycetes. Approved Standard, Wayne PA : NCCLS : 2003. Document No. M24-A.
21. Finch CK, Chrisman CR, Baciewicz AM, Self TH. Rifampin and rifabutin drug interactions: An update. Arch Int Med 2002 162 : 985 992.
22. McGregor MM, Olliaro P, Wolmarons L et al. Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis. Am J Resp Crit Care Med 1996 154 : 1462 1467.
23. Ferrari SL, Goffin E, Mourad M, Wallemacq P, Squifflet J-P, Pirson Y. The interaction between clarithromycin and cyclosporine in kidney transplant recipients. Transplantation 1994 58 : 725 727.
24. Plemmons RM, McAllister K, Garces MC, Ward RL. Osteomyelitis due to Mycobacterium haemophilum in a cardiac transplant patient: Case report and analysis of interactions among clarithromycin, rifampin and cyclosporine. Clin Infect Dis 1997 24 : 995 997.
25. Wallace RJ Jr., Tanner D, Brennan PJ, Brown B. Clinical Trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993 119 : 482 486.
26. Chaisson RE, Benson CA, Dube MP et al. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. N Engl J Med 1994 121 : 905 911.
27. Campbell IA, Jenkins PA. Mycobacterium kansasii. In : Schlossberg D, ed. Tuberculosis and Nontuberculous Mycobacterial Infections, 4th Ed. Philadelphia : Saunders, 1999 : 380 385.
28. Shafran SD, Singer J, Zarowny DP et al. A comparison of two regimens for treatment of Mycobacterium avium complex bacteremia in AIDS: Rifabutin, ethambutol and clarithromycin versus rifampin, ethambutol, clofazamine and ciprofloxacin. N Engl J Med 1996 335 : 377 383.
29. Bernard L, Vincent V, Lortholary O et al. Mycobacterium kansasii septic arthritis: French retrospective study of 5 years and review. Clin Infect Dis 1999 29 : 1455 1460.
30. Brown-Elliot BA, Wallace RJ Jr., Blinkhorn R, Crist CJ, Mann LB. Successful treatment of disseminated Mycobacteriuim chelonae infection with linezolid. Clin Infect Dis 2001 33 : 1433 1434.
31. Fernández-Roblas R, Martín-de-Hijas NZ, Fernández-Martinez AI, García-Almeida D, Gadea I, Estaban J. In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria. Antimicrob Agents Chemother 2008 52 : 4184 4186.
32. Wallace RJ Jr., Brown-Elliott BA, Crist CJ, Mann L, Wilson RW. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Atimicrob Agents Chemother 2002 46 : 3164 3167.
33. Gordin FM, Sullam PM, Shafran SD et al. A randomized placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacerium avium complex. Clin Inf Dis 1999 28 : 1080 1085.
34. Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ Jr. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex. Clin Infect Dis 2000 30 : 288 292.